Nuove prospettive nella riduzione del rischio cardiovascolare: Focus su HDL

Translated title of the contribution: New perspectives in cardiovascular risk reduction: Focus on HDL

Stefania Paolillo, Giuseppe Luca Della Ratta, Alice Vitagliano, Annapaola Cirillo, Elisabetta Lardino, Tiziana Formisano, Irma Fabiani, Angela Maria Pellegrino, Pietro Riello, Pasquale Perrone Filardi

Research output: Contribution to journalArticlepeer-review


Cardiovascular diseases represent the leading cause of morbidity and mortality worldwide, mostly contributing to hospitalizations and health care costs. Dyslipidemias represent one of the major cardiovascular risk factor and its management, throughout life-style modifications and pharmacological interventions, has shown to reduce cardiac events. The risk of adverse cardiovascular events is related not only to elevated LDL blood levels, but also to decreased HDL concentrations, that exhibit protective effects in the development of atherosclerotic process. Aim of this review is to summarize current evidences about defensing effects of such lipoproteins and to show the most recent pharmacological strategies to reduce cardiovascular risk through the increase of their circulating levels.

Translated title of the contributionNew perspectives in cardiovascular risk reduction: Focus on HDL
Original languageItalian
Pages (from-to)27-30
Number of pages4
JournalMonaldi Archives for Chest Disease - Cardiac Series
Issue number1
Publication statusPublished - Mar 2013

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'New perspectives in cardiovascular risk reduction: Focus on HDL'. Together they form a unique fingerprint.

Cite this